FCA
FLGT icon

FinTrust Capital Advisors’s Fulgent Genetics FLGT Stock Holding History

FinTrust Capital Advisors’s Portfolio FLGT Stock Details FLGT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-10
Closed -$1K – 1240
2022
Q1 		$1K Hold
10
– – ﹤0.01% 1172
2021
Q4 		$1K Buy
+10
New +$879 ﹤0.01% 1145
2021
Q1 		– Sell
-700
Closed -$36K – 1152
2020
Q4 		$36K Buy
700
+610
+678% +$25.5K 0.01% 545
2020
Q3 		$4 Buy
+90
New +$2.82K ﹤0.01% 980

Other funds holding FLGT

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
PWAM
Park West Asset Management San Francisco, California $1.18B AUM 47.25% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Pacer Advisors
Pacer Advisors Malvern, Pennsylvania $35.6B AUM 18.19% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

FinTrust Capital Advisors's FLGT Position: Q2 2022 in Review

FinTrust Capital Advisors sold out of Fulgent Genetics (FLGT) in Q2 2022, closing a stake of 10 shares — an estimated $1K sold.

FinTrust Capital Advisors first reported a position in FLGT in Q3 2020 and held it in 4 quarters. The position peaked at $36K in Q4 2020. 262 funds tracked by Wall St. Rank hold FLGT as of Q2 2022.

  • FinTrust Capital Advisors reported no remaining Fulgent Genetics position as of Q2 2022 after selling out during the quarter.
  • FinTrust Capital Advisors sold 10 Fulgent Genetics shares in Q2 2022, an estimated $1K.
  • FinTrust Capital Advisors first reported a position in Fulgent Genetics in Q3 2020 and held it in 4 quarters.
  • FinTrust Capital Advisors's Fulgent Genetics position peaked at $36K in Q4 2020.
  • 262 funds tracked by Wall St. Rank held Fulgent Genetics as of Q2 2022.

Based on FinTrust Capital Advisors's 13F filing for Q2 2022, filed 26 Jul 2022.